Results 321 to 330 of about 767,651 (360)
Some of the next articles are maybe not open access.
JAMA
This JAMA Insights discusses lipoprotein(a), including factors associated with elevated lipoprotein(a) levels, how to manage them, and atherosclerotic cardiovascular disease risk.
Samia, Mora, Florian, Kronenberg
openaire +2 more sources
This JAMA Insights discusses lipoprotein(a), including factors associated with elevated lipoprotein(a) levels, how to manage them, and atherosclerotic cardiovascular disease risk.
Samia, Mora, Florian, Kronenberg
openaire +2 more sources
Lipoprotein(a) and atherogenesis
Trends in Cardiovascular Medicine, 1994Lipoprotein(a) is a major inherited risk factor for atherosclerosis. Many of its activities depend on its plasminlike component, apolipoprotein(a). In vitro studies suggest that apolipoprotein(a) could enhance lipid deposition through binding to sites in the vessel wall, interfere with fibrinolysis, and modulate smooth muscle cell activity.
Richard M. Lawn, Alexander C. Liu
openaire +3 more sources
Current Opinion in Lipidology, 2016
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Olga I. Afanasieva+2 more
openaire +2 more sources
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Olga I. Afanasieva+2 more
openaire +2 more sources
Perfusion, 1997
A broad range of molecular and cellular interactions contribute to various pathophysiological alterations in haemostasis. Recent studies have shown strong links between lipoproteins and coagulation factors. Findings suggest that lipoproteins play an important role in the fibrinolytic and thrombogenic mechanisms that influence the risks of patients in ...
Annette Basile-Borgia, John H. Abel
openaire +3 more sources
A broad range of molecular and cellular interactions contribute to various pathophysiological alterations in haemostasis. Recent studies have shown strong links between lipoproteins and coagulation factors. Findings suggest that lipoproteins play an important role in the fibrinolytic and thrombogenic mechanisms that influence the risks of patients in ...
Annette Basile-Borgia, John H. Abel
openaire +3 more sources
High density lipoprotein and lipoprotein oxidation
Current Opinion in Lipidology, 1996HDL protects LDL from oxidative damage known to contribute to the onset and progression of atherosclerosis. This antioxidant protection by HDL is mediated by intrinsic hydrolytic enzyme systems, by accelerated selective uptake of lipid peroxides from HDL and by antioxidant molecules.
openaire +3 more sources
Lipoprotein Molecule or Lipoprotein Particle?
1978May I wind up this Advanced Study Institute by sketching briefly what this course has meant at least as far as my judgement goes. Not that I believe to be a polyvalent expert on all topics presented but I do think it is my duty to outline the status of our knowledge and the avenues along which we should make progress.
openaire +2 more sources
Clinical laboratory, 2010
Lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease. There is as yet controversy on serum Lp(a) concentrations in the elderly population.We investigated 2128 medical outpatients who consecutively attended our laboratory between January 2006 and June 2008 for Lp(a) and routine serum lipid assessment.
Lippi G.+5 more
openaire +3 more sources
Lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease. There is as yet controversy on serum Lp(a) concentrations in the elderly population.We investigated 2128 medical outpatients who consecutively attended our laboratory between January 2006 and June 2008 for Lp(a) and routine serum lipid assessment.
Lippi G.+5 more
openaire +3 more sources